#news #biotech Provention will wait for FDA to ‘opine’ on new data after teplizumab rejection, eyes Q4 for further talks

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Provention will wait for FDA to ‘opine’ on new data after teplizumab rejection, eyes Q4 for further talks .Provention will wait for FDA to ‘opine’ on new data after teplizumab rejection, eyes Q4 for further talks
badams
Mon, 09/13/2021 – 09:37

from FierceBiotech: Biotech https://ift.tt/3nyyOLn